Literature DB >> 3080049

The kidney in myeloma.

T J Hamblin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3080049      PMCID: PMC1338967          DOI: 10.1136/bmj.292.6512.2

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  15 in total

1.  Renal function in patients with multiple myeloma.

Authors:  R A DeFronzo; C R Cooke; J R Wright; R L Humphrey
Journal:  Medicine (Baltimore)       Date:  1978-03       Impact factor: 1.889

2.  Effects on rat kidney slice function in vitro of proteins from the urines of patients with myelomatosis and nephrosis.

Authors:  H G Preuss; F R Weiss; R M Iammarino; W J Hammack; H V Murdaugh
Journal:  Clin Sci Mol Med       Date:  1974-03

3.  Immunofluorescent studies of the myeloma kidney with special reference to light chain disease.

Authors:  D F Levi; R C Williams; F D Lindstrom
Journal:  Am J Med       Date:  1968-06       Impact factor: 4.965

4.  Resolution of amyloidosis and plasma-cell dyscrasia with combination chemotherapy.

Authors:  J Corkery; M M Bern; J L Tullis
Journal:  Lancet       Date:  1978-08-19       Impact factor: 79.321

5.  Structure and function of the kidney in multiple myeloma.

Authors:  G E Schubert; J Veigel; K Lennert
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

6.  Management and prognosis of multiple myeloma.

Authors:  R A Kyle; L R Elveback
Journal:  Mayo Clin Proc       Date:  1976-12       Impact factor: 7.616

7.  Nephrotoxicity of Bence Jones proteins in the rat: importance of protein isoelectric point.

Authors:  D H Clyne; A J Pesce; R E Thompson
Journal:  Kidney Int       Date:  1979-09       Impact factor: 10.612

8.  The urinary myeloma cast. Frequency of detection and clinical correlations in 30 patients with multiple myeloma.

Authors:  B D Cheson; C C De Bellis; G B Schumann; J L Schumann
Journal:  Am J Clin Pathol       Date:  1985-04       Impact factor: 2.493

9.  "Idiopathic" Bence Jones proteinuria: long-term follow-up in seven patients.

Authors:  R A Kyle; P R Greipp
Journal:  N Engl J Med       Date:  1982-03-11       Impact factor: 91.245

10.  Inhibition of active-transport sodium-potassium-A.T.P.ase by myeloma protein.

Authors:  J McGeoch; J Falconer Smith; J Ledingham; B Ross
Journal:  Lancet       Date:  1978-07-01       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.